Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment Strategy in Patients With High-risk of Postextubation Distress in ICU Based on a Lung Ultrasound Score Versus Standard Strategy

NCT02123940 is registered in ClinicalTrials.gov with University Hospital, Clermont-Ferrand as lead sponsor.

NCT NCT02123940
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02123940 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment Strategy in Patients With High-risk of Postextubation Distress in ICU Based on a Lung Ultrasound Score Versus Standard Strategy
Lead sponsor
University Hospital, Clermont-Ferrand
Phase
Phase 3
Overall status
Completed
Start date
February 28, 2014
Completion date
August 25, 2018
Enrollment
483 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adult patients ventilated more than 48 h